Companies with normal risk readings
Companies with normal risk readings: 4,584 companies ranked by a composite risk reading built from filed statements -- leverage, cash conversion, operating pressure, customer and supplier concentration and competitive position. Recomputed 21 October 2026.
Composite readings for 14,899 companies, recomputed 21 October 2026. A company appears here once at least three weighted categories cleared their inputs; the rest carry per-mechanism readings without a headline.
| Company | Reading | Band | Sector | Country | Coverage | Market cap |
|---|---|---|---|---|---|---|
| Qinetiq Group PLC QQ | 38 | Normal | Industrials | United Kingdom | 5 / 6 | $3.2B |
| SMG Swiss Marketplace Group Holding AG SMG.SW | 30 | Normal | Communication Services | Switzerland | 4 / 6 | $3.2B |
| American States Water Company AWR | 31 | Normal | Utilities | United States | 4 / 6 | $3.2B |
| Figs Inc - Class A FIGS | 36 | Normal | Consumer Cyclical | United States | 4 / 6 | $3.2B |
| dormakaba Holding AG KAB0 | 39 | Normal | Industrials | Switzerland | 5 / 6 | $3.2B |
| Lingbao Gold Group Company Ltd. 3330.HK | 36 | Normal | Basic Materials | China | 5 / 6 | $3.2B |
| Freshpet Inc FRPT | 31 | Normal | Consumer Defensive | United States | 6 / 6 | $3.2B |
| Keppel REIT K71U.SI | 37 | Normal | Real Estate | Singapore | 5 / 6 | $3.2B |
| OSI Systems Inc OSIS | 33 | Normal | Technology | United States | 6 / 6 | $3.2B |
| Treasury Wine Estates Ltd TWE | 30 | Normal | Consumer Defensive | Australia | 4 / 6 | $3.2B |
| Agilysys Inc AGYS | 30 | Normal | Technology | United States | 5 / 6 | $3.2B |
| Hill & Smith Holdings PLC HILS | 35 | Normal | Industrials | United Kingdom | 5 / 6 | $3.2B |
| Black Stone Minerals L.P. BSM | 29 | Normal | Energy | United States | 6 / 6 | $3.2B |
| Highwoods Properties Inc HIW | 31 | Normal | Real Estate | United States | 5 / 6 | $3.1B |
| AvePoint Inc - Class A AVPT | 32 | Normal | Technology | United States | 6 / 6 | $3.1B |
| Ligent Technologies, Inc. 9856.HK | 34 | Normal | Technology | China | 5 / 6 | $3.1B |
| Breville Group Limited BRG.AX | 37 | Normal | Consumer Cyclical | Australia | 4 / 6 | $3.1B |
| SPS Commerce Inc SPSC | 34 | Normal | Technology | United States | 5 / 6 | $3.1B |
| Fameglow Holdings Limited 3774.HK | 31 | Normal | Consumer Cyclical | Hong Kong | 5 / 6 | $3.1B |
| Warby Parker Inc - Class A WRBY | 36 | Normal | Healthcare | United States | 5 / 6 | $3.1B |
| MINISO Group Holding Ltd MNSO | 35 | Normal | Consumer Cyclical | China | 5 / 6 | $3.1B |
| PennyMac Financial Services Inc PFSI | 27 | Normal | Financial Services | United States | 3 / 6 | $3.1B |
| PagSeguro Digital Ltd - Class A PAGS | 24 | Normal | Technology | Brazil | 5 / 6 | $3.1B |
| Giant Biogene Holding Co., Ltd. 2367.HK | 27 | Normal | Consumer Defensive | China | 5 / 6 | $3.1B |
| Sugi Holdings Co.,Ltd. 7649.T | 37 | Normal | Healthcare | Japan | 5 / 6 | $3.0B |
| Interparfums SA ITP.PA | 29 | Normal | Consumer Defensive | France | 6 / 6 | $3.0B |
| Enerflex Ltd EFXT | 31 | Normal | Energy | Canada | 5 / 6 | $3.0B |
| Enav SpA ENAV.MI | 37 | Normal | Basic Materials | Italy | 3 / 6 | $3.0B |
| Rinnai Corporation 5947.T | 39 | Normal | Consumer Cyclical | Japan | 5 / 6 | $3.0B |
| Kamigumi Co., Ltd. 9364.T | 39 | Normal | Industrials | Japan | 5 / 6 | $3.0B |
| Ideaya Biosciences Inc IDYA | 35 | Normal | Healthcare | United States | 5 / 6 | $3.0B |
| China Ruyi Holdings Limited 0136.HK | 30 | Normal | Communication Services | Hong Kong | 5 / 6 | $3.0B |
| Knowles Corp KN | 37 | Normal | Technology | United States | 6 / 6 | $3.0B |
| Red Rock Resorts Inc - Class A RRR | 35 | Normal | Consumer Cyclical | United States | 4 / 6 | $3.0B |
| BIC BB.PA | 38 | Normal | Consumer Defensive | France | 6 / 6 | $2.9B |
| Alleima AB (publ) ALLEI | 35 | Normal | Basic Materials | Sweden | 5 / 6 | $2.9B |
| Taseko Mines Ltd TGB | 36 | Normal | Basic Materials | Canada | 5 / 6 | $2.9B |
| Elecnor, S.A. ENO.MC | 39 | Normal | Industrials | Spain | 5 / 6 | $2.9B |
| Royal Unibrew A/S RBREW | 35 | Normal | Consumer Defensive | Denmark | 3 / 6 | $2.9B |
| Helios Towers Plc HTWS | 23 | Normal | Communication Services | United Kingdom | 5 / 6 | $2.9B |
| Guoco Group Limited 0053.HK | 33 | Normal | Industrials | Hong Kong | 5 / 6 | $2.9B |
| Virbac SA VIRP | 38 | Normal | Healthcare | France | 5 / 6 | $2.9B |
| Lagardere SCA MMB | 38 | Normal | Consumer Cyclical | France | 5 / 6 | $2.9B |
| TECHNOGYM TGYM.MI | 30 | Normal | Consumer Cyclical | Italy | 5 / 6 | $2.9B |
| Gulfport Energy Corp (New) GPOR | 26 | Normal | Energy | United States | 4 / 6 | $2.9B |
| Kyivstar Group Ltd KYIV | 32 | Normal | Communication Services | United Arab Emirates | 4 / 6 | $2.9B |
| NetLink NBN Trust CJLU.SI | 39 | Normal | Communication Services | Singapore | 5 / 6 | $2.9B |
| Nifco Inc. 7988.T | 37 | Normal | Consumer Cyclical | Japan | 5 / 6 | $2.9B |
| Danaos Corporation DAC | 37 | Normal | Industrials | Greece | 5 / 6 | $2.8B |
| Onewo Inc. 2602.HK | 37 | Normal | Real Estate | China | 5 / 6 | $2.8B |
| IHS Holding Ltd IHS | 30 | Normal | Real Estate | United Kingdom | 5 / 6 | $2.8B |
| Imax Corp IMAX | 27 | Normal | Communication Services | Canada | 6 / 6 | $2.8B |
| TGS TGS.OL | 22 | Normal | Energy | Norway | 3 / 6 | $2.8B |
| Netscout Systems Inc NTCT | 37 | Normal | Technology | United States | 5 / 6 | $2.8B |
| Tootsie Roll Industries Inc TR | 36 | Normal | Consumer Defensive | United States | 6 / 6 | $2.8B |
| Huron Consulting Group Inc HURN | 37 | Normal | Industrials | United States | 5 / 6 | $2.8B |
| Bufab BUFAB.ST | 37 | Normal | Industrials | Sweden | 4 / 6 | $2.8B |
| Cellebrite DI Ltd CLBT | 29 | Normal | Technology | Israel | 5 / 6 | $2.8B |
| Curbline Properties Corp CURB | 22 | Normal | Real Estate | United States | 4 / 6 | $2.8B |
| CarGurus Inc - Class A CARG | 39 | Normal | Communication Services | United States | 5 / 6 | $2.8B |
| Soleno Therapeutics Inc SLNO | 36 | Normal | Healthcare | United States | 4 / 6 | $2.8B |
| Diamondrock Hospitality Company DRH | 36 | Normal | Real Estate | United States | 5 / 6 | $2.8B |
| Medacta Group SA MOVE.SW | 39 | Normal | Healthcare | Switzerland | 5 / 6 | $2.7B |
| McGrath Rentcorp MGRC | 27 | Normal | Industrials | United States | 5 / 6 | $2.7B |
| Sankyo Co., Ltd. 6417.T | 35 | Normal | Consumer Cyclical | Japan | 4 / 6 | $2.7B |
| Seino Holdings Co., Ltd. 9076.T | 39 | Normal | Industrials | Japan | 5 / 6 | $2.7B |
| Daetwyl I DAE | 39 | Normal | Industrials | Switzerland | 5 / 6 | $2.7B |
| Workman Co.,Ltd. 7564.T | 35 | Normal | Consumer Cyclical | Japan | 5 / 6 | $2.7B |
| Mao Geping Cosmetics Co., Ltd. 1318.HK | 36 | Normal | Consumer Defensive | China | 4 / 6 | $2.7B |
| Bumitama Agri Ltd 2BU | 31 | Normal | Consumer Defensive | Indonesia | 5 / 6 | $2.7B |
| Nurix Therapeutics Inc NRIX | 35 | Normal | Healthcare | United States | 5 / 6 | $2.7B |
| Liftoff Mobile, Inc. LFTO | 34 | Normal | Communication Services | United States | 5 / 6 | $2.7B |
| WD-40 Company WDFC | 33 | Normal | Basic Materials | United States | 6 / 6 | $2.7B |
| Zai Lab Ltd ZLAB | 36 | Normal | Healthcare | China | 6 / 6 | $2.7B |
| Fujitec Co.Ltd FJC | 39 | Normal | Industrials | Japan | 5 / 6 | $2.7B |
| TRIGANO TRI.PA | 38 | Normal | Consumer Cyclical | France | 5 / 6 | $2.7B |
| Lerøy Seafood Group ASA LSG | 37 | Normal | Consumer Defensive | Norway | 4 / 6 | $2.7B |
| REN - Redes Energéticas Nacionais SGPS S.A RENE | 31 | Normal | Utilities | Portugal | 4 / 6 | $2.7B |
| DANIELI & C RISP DANR.MI | 33 | Normal | Industrials | Italy | 3 / 6 | $2.7B |
| StoneCo Ltd - Class A STNE | 30 | Normal | Technology | Cayman Islands | 5 / 6 | $2.6B |
| Mabuchi Motor Co., Ltd. 6592.T | 30 | Normal | Consumer Cyclical | Japan | 5 / 6 | $2.6B |
| Frasers Logistics & Commercial Trust BUOU.SI | 39 | Normal | Real Estate | Singapore | 5 / 6 | $2.6B |
| Kotobuki Spirits Co., Ltd. 2222.T | 24 | Normal | Consumer Defensive | Japan | 5 / 6 | $2.6B |
| Central Garden & Pet Company CENT | 38 | Normal | Consumer Defensive | United States | 6 / 6 | $2.6B |
| Green Brick Partners Inc GRBK | 36 | Normal | Consumer Cyclical | United States | 5 / 6 | $2.6B |
| Visional, Inc. 4194.T | 22 | Normal | Communication Services | Japan | 4 / 6 | $2.6B |
| Guardian Pharmacy Services Inc GRDN | 31 | Normal | Healthcare | United States | 5 / 6 | $2.5B |
| SIA Engineering Company Limited S59.SI | 39 | Normal | Industrials | Singapore | 5 / 6 | $2.5B |
| OEM International AB (publ) OEM-B | 27 | Normal | Industrials | Sweden | 4 / 6 | $2.5B |
| Theon International Plc THEON | 38 | Normal | Industrials | Cyprus | 5 / 6 | $2.5B |
| Dai-Dan Co., Ltd. 1980.T | 28 | Normal | Industrials | Japan | 5 / 6 | $2.5B |
| Sanki Engineering Co., Ltd. 1961.T | 36 | Normal | Industrials | Japan | 5 / 6 | $2.5B |
| Greggs PLC GRG | 39 | Normal | Consumer Cyclical | United Kingdom | 5 / 6 | $2.5B |
| Grindr Inc - Class A GRND | 29 | Normal | Technology | United States | 6 / 6 | $2.5B |
| Titan America SA TTAM | 33 | Normal | Basic Materials | Belgium | 5 / 6 | $2.5B |
| Beam Therapeutics Inc BEAM | 36 | Normal | Healthcare | United States | 5 / 6 | $2.5B |
| Adma Biologics Inc ADMA | 39 | Normal | Healthcare | United States | 6 / 6 | $2.5B |
| Koninklijke Heijmans N.V. HEIJM | 36 | Normal | Industrials | Netherlands | 5 / 6 | $2.5B |
| Navios Maritime Partners L.P. NMM | 37 | Normal | Industrials | Greece | 4 / 6 | $2.5B |
| Transmedics Group Inc TMDX | 24 | Normal | Healthcare | United States | 5 / 6 | $2.5B |
By sector
Industrials 3,117Technology 2,425Consumer Cyclical 2,231Healthcare 1,695Consumer Defensive 1,055Basic Materials 1,055Real Estate 1,011Communication Services 956Energy 487Utilities 343Financial Services 90
How the reading is built
Each company is scored on six mechanisms -- market expectation, operating pressure, cash conversion, leverage, concentration and competitive position -- from its own filed statements. A mechanism whose inputs do not clear its coverage floor is left unread rather than scored zero, and a reading built on thin coverage is pulled toward a neutral prior rather than claiming safety from what nobody looked at.
Descriptive, not advisory. These bands describe measured mechanisms; they are not investment advice, not a forecast, and not a statement about whether a share is worth owning.